Comment by
lscfa on Oct 17, 2015 11:38am
This post has been removed in accordance with Community Policy
Comment by
Craigbad on Oct 17, 2015 12:35pm
Get freaking real. 2016 eps estimate $0.69 X 15 p/e multiple = $10.35.... Read more at https://www.stockhouse.com/companies/bullboard/bullboard/t.nhc/nobilis-health-corp#8r2dbACH80UdqmSV.99 i used the same multiple you were using on the nhc board iscfa. Multiples are multiples. With a 34% reduction in profit targets, maybe the model isn't working.
Comment by
lscfa on Oct 17, 2015 1:22pm
This post has been removed in accordance with Community Policy
Comment by
ocean112 on Oct 29, 2015 10:49pm
PS - if you insist on using PE multiple...it would be more appropriate to use PEG ratio (PE/Growth). If we assume 25% growth - current PEG comes in at 0.72 assuming 0.04 EPS...(18/25).....undervalued (anything less than 1). Anyway - multiples, PEG, EBITDA, Rev growth - are all metrics that should be used together to make a call on a stock - not just one "multiple". DYDD
Comment by
gibbonsj on Oct 29, 2015 8:11pm
what you say has merit, I'm on the sideline until we see .60. Even then I see no reason why .55 is not in the cards. I've often wondered why LimeLight LLNW and NLN don't vend. A friendly merger.